Journal of Natural Products · 2014 · 45 citations · 20 references
Life SciencesBiochemistryMicrobiologyDrug DiscoveryMicrobial MetabolismNatural Product BiosynthesisAntibacterial AgentsAntibiotic ProductionFungal Natural Product BiosynthesisFungal Secondary MetabolitesMicrobial Metabolite ProductionMicrobial Natural Product BiosynthesisBiological Evaluation ReportBiosynthetic Pathway ConstructionDe Novo Structure ElucidationEndophyte IsolationEndophyte Secondary MetabolismProduction Of Antimicrobial CompoundsRecombinant Enzyme ExpressionRecombinant Expression Systems
Three new decalin-type tetramic acid analogues, pyrrolocins A (1), B (2), and C (3), were defined as products of a metabolic pathway from a fern endophyte, NRRL 50135, from Papua New Guinea. NRRL 50135 initially produced 1 but ceased its production before chemical or biological evaluation could be completed. Upon transfer of the biosynthetic pathway to a model host, 1-3 were produced. All three compounds are structurally related to equisetin-type compounds, with 1 and 3 having a trans-decalin ring system, while 2 has a cis-fused decalin. All were active against Mycobacterium tuberculosis, with the trans-decalin analogues 1 and 3 exhibiting lower MICs than the cis-decalin analogue 2. Here we report the isolation, structure elucidation, and antimycobacterial activities of 1-3 from the recombinant expression as well as the isolation of 1 from the wild-type fungus NRRL 50135.
20
Bao-Ning Su, Eun‐Jung Park, Zakaria H. Mbwambo et al. · Journal of Natural Products · 2002 · 199 citations